| P2093 | author name string | Tian Zhao | |
| | Marian Iwamoto | |
| | Adedayo Adedoyin | |
| | S Aubrey Stoch | |
| | Deborah Panebianco | |
| | Jacqueline B McCrea | |
| | Charles Tomek | |
| | Craig Fancourt | |
| | Karsten Menzel | |
| P2860 | cites work | Pharmacokinetics of antifungal agents in onychomycoses | Q34320789 |
| | Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? | Q34490092 |
| | The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase | Q38631773 |
| | Clinical pharmacokinetics of fluconazole | Q40884105 |
| | The pharmacokinetics of fluconazole in healthy Chinese adult volunteers: influence of ethnicity and gender | Q43067618 |
| | Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation. | Q45955430 |
| | Gender differences in the oral pharmacokinetics of fluconazole | Q46894977 |
| | Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses | Q48666983 |
| | Intravenous Hydroxypropyl β-Cyclodextrin Formulation of Letermovir: A Phase I, Randomized, Single-Ascending, and Multiple-Dose Trial. | Q50546849 |
| | Pharmacokinetics and Safety of Letermovir Coadministered With Cyclosporine A or Tacrolimus in Healthy Subjects. | Q53807644 |
| | Induction of fluconazole metabolism by rifampin: in vivo study in humans. | Q54079254 |
| | Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review. | Q64993136 |
| | Effect of repeated dosing on the pharmacokinetics of oral fluconazole in bone marrow transplant patients | Q74321682 |
| | Pharmacokinetics and Tolerability of Letermovir Coadministered With Azole Antifungals (Posaconazole or Voriconazole) in Healthy Subjects | Q88173355 |
| | PBPK Modeling Strategy for Predicting Complex Drug Interactions of Letermovir as a Perpetrator in Support of Product Labeling | Q89100456 |
| | Pharmacogenetic Analysis of OATP1B1, UGT1A1, and BCRP Variants in Relation to the Pharmacokinetics of Letermovir in Previously Conducted Clinical Studies | Q91510806 |
| | Pharmacokinetics of Tacrolimus Coadministered With Letermovir in Allogeneic Hematopoietic Stem Cell Transplantation Patients | Q92165424 |
| | Pharmacokinetic Drug-Drug Interactions Between Letermovir and the Immunosuppressants Cyclosporine, Tacrolimus, Sirolimus, and Mycophenolate Mofetil | Q93128495 |
| P921 | main subject | fluconazole | Q411478 |
| P577 | publication date | 2020-07-22 | |
| P1433 | published in | Clinical pharmacology in drug development | Q27726600 |
| P1476 | title | Assessment of Pharmacokinetic Interaction Between Letermovir and Fluconazole in Healthy Participants | |